AlloSkin™ AC is a meshed dermis-only human skin allograft that has been decellularized while preserving the natural biologic components and structure of the dermal matrix.
• Provides a favorable microenvironment for bio-ingrowth, resulting in rapid revascularization and cellular repopulation
• Provides a scaffold onto which the body can rebuild dermal tissue, making a single application often sufficient for healing
• Ready-to-use graft eliminates clinical time needed to thaw a frozen product or to rehydrate a freeze-dried product
• Pliable, stretchable tissue allows graft contouring to wound topography, and maintenance of wound bed contact
• Robust enough to suture or staple graft without tearing
• Meshing encourages fluid draining from wound and allows for bolstering by NPWT
AlloSkin™ AC may be used as a wound covering for partial- and full-thickness wounds, including chronic wounds, burns and traumatic injuries, or for other homologous uses, including those where substructures such as bone, ligament, nerve or muscle are exposed.
Patients exhibiting autoimmune connective tissue disease and the presence of gross infection at the transplantation site are contraindications.
As with all biological products, the tissue from AlloSkin™ AC has the potential to transmit infectious agents despite processing treatments, extensive donor screening, tissue selection and laboratory tests. See package insert for full listing.
Inherent uncertainty exists in medical and social histories and laboratory testing which may not detect known or unknown pathogens. Therefore, the following complications may occur with tissue transplantation: loss of integrity of transplanted tissue, immune response to transplanted tissue, transmission of known pathogens, and transmission or causation of disease of unknown etiology and characteristics. Adverse outcomes potentially attributable to AlloSkin™ AC must be promptly reported to the manufacturer. See package insert for full listing.
Tissue is packaged in sterile water and should be stored at ambient temperature. Do not refrigerate, freeze, or expose to extreme heat. Tissue shelf life as listed on the product label is two years.
|Assigned HCPCS code||●|
|Shelf life greater than 2 years|
|Shelf life limited|
|Indicated for acute wounds||●|
|Indicated for chronic wounds||●|
|Indicated for diabetic ulcers||●|
|Indicated for pressure ulcers||●|
|Indicated for surgical wounds||●|
|Indicated for third-degree burns|
|Indicated for venous ulcers||●|
|Contact manufacturer for usage guidelines|
|Educational Material Available||●|
|Free Samples/Trials Available||●|
|Published Clinical Article Available|
Non/Minimally Exudating Wounds
Ensure wound is adequately debrided and free of infection. Rinse in saline or sterile isotonic solution prior to applying to the wound. Affix AlloSkin™ AC per physician preference: can be stapled, sutured, or tacked.
AlloSkin™ AC is designed for a single application. Inspect wound weekly, sooner if deemed necessary. Depending on periodic wound assessment, clinician may leave graft in place for incorporation and/or apply an additional application of AlloSkin™ AC where needed.
Apply any combination of non-adherent sterile dressing over AlloSkin™ AC.
AlloSource is a non-profit organization that offers more than 200 types of precise skin, bone, soft-tissue, and other allografts for use in an array of life-saving and life-enhancing medical procedures.